Skip to main content
INCYHealthcare

Incyte Corp. (INCY) Insider Trading

In the last 90 days, 2 Incyte Corp. (INCY) insiders reported no open-market purchases and 7 sales totaling $13,061,820. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 15, 2026Pablo J CagnoniPresident, Global Head of R&DSale2,642$112.71$297,780
Sep 15, 2026Pablo J CagnoniPresident, Global Head of R&DSale23,218$120.49$2,797,630
Aug 19, 2026Pablo J CagnoniPresident, Global Head of R&DSale10,801$125.56$1,356,174
Aug 12, 2026Pablo J CagnoniPresident, Global Head of R&DSale10,803$120.04$1,296,792
Aug 5, 2026Patrick A MayesEVP & Chief Scientific OfficerSale2,207$123.99$273,646
Aug 5, 2026Pablo J CagnoniPresident, Global Head of R&DSale10,640$122.69$1,305,422
Aug 3, 2026Patrick A MayesEVP & Chief Scientific OfficerSale47,954$119.58$5,734,378
Jul 31, 2026Pablo J CagnoniPresident, Global Head of R&DSale15,888$119.70$1,901,794
Jul 16, 2026Mohamed Khairie IssaEVP, Head of U.S. CommercialSale1,093$115.01$125,706
Jul 16, 2026Steven H SteinCMO & Head of Late-Stage Dev.Sale1,877$114.73$215,348

Common questions

INCY insider trading FAQ

Are INCY insiders buying or selling?
Over the last 90 days, INCY insiders were net sellers, reporting $0.00 of open-market purchases and $13,061,820 of sales.
When was the last INCY insider purchase?
No open-market insider purchase of Incyte Corp. stock was reported in the last 90 days.
Where does INCY insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Incyte Corp. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.